Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients

Liver Transplantation

Volumn 20, Issue 10, 2014, Pages 1168-1177

  Supelana, Christina ^a,b   Annunziato, Rachel A ^a,b   Schiano, Thomas D ^a   Anand, Ravinder ^c   Vaidya, Swapna ^a   Chuang, Kelley ^a   Zack, Yelena ^a   Florman, Sander ^a   Shneider, Benjamin L ^d   Shemesh, Eyal ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b FORDHAM UNIVERSITY   (United States)

^c EMMES CORPORATION   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; MEDICATION LEVEL VARIABILITY INDEX; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT COMPLIANCE; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SECONDARY ANALYSIS; TREATMENT REFUSAL; ADOLESCENT; BIOPSY; CHILD; GRAFT REJECTION; INFANT; MIDDLE AGED; PRESCHOOL CHILD; PROGNOSIS; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; STATISTICS AND NUMERICAL DATA; TIME; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEW YORK; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; ROC CURVE; TIME FACTORS; TRANSPLANT RECIPIENTS; YOUNG ADULT;

EID: 84908506524     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23930     Document Type: Article

References (37)

1. Shemesh E, Shneider BL, Emre S. Adherence to medical recommendations in pediatric transplant recipients: time for action. Pediatr Transplant 2008;12:281-283.
2. Shemesh E, Shneider BL, Savitzky JK, Arnott L, Gondolesi GE, Krieger NR, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004;113:825-832.
3. Shemesh E. Non-adherence to medications following pediatric liver transplantation. Pediatr Transplant 2004; 8:600-605.
4. Molmenti E, Mazariegos G, Bueno J, Cacciarelli T, Alasio T, Khanna A, et al. Noncompliance after pediatric liver transplantation. Transplant Proc 1999;31:408.
5. Shemesh E, Lurie S, Stuber ML, Emre S, Patel Y, Vohra P, et al. A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics 2000;105:E29.
6. Venkat VL, Nick TG, Wang Y, Bucuvalas JC. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence. Pediatr Transplant 2008;12:67-72.
7. Stuber ML, Shemesh E, Seacord D, Washington J III, Hellemann G, McDiarmid S. Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Transplant 2008;12:284-288.
8. Mor E, Gonwa TA, Husberg BS, Goldstein RM, Klintmalm GB. Late-onset acute rejection in orthotopic liver transplantation-associated risk factors and outcome. Transplantation 1992;54:821-824.
9. National Institute of Diabetes and Digestive and Kidney Diseases. Action plan for liver disease research: executive summary. http://archives.niddk.nih.gov/AboutNiddk/documents/ldrb-executive-summary.pdf. Accessed July 2013.
10. Bucuvalas JC, Alonso E, Magee JC, Talwalkar J, Hanto D, Doo E. Improving long-term outcomes after liver transplantation in children. Am J Transplant 2008;8: 2506-2513.
11. Pollock-Barziv SM, Finkelstein Y, Manlhiot C, Dipchand AI, Hebert D, Ng VL, et al. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children. Pediatr Transplant 2010;14:968-975.
12. Shemesh E, Annunziato RA, Shneider BL, Dugan CA, Warshaw J, Kerkar N, Emre S. Improving adherence to medications in pediatric liver transplant recipients. Pediatr Transplant 2008;12:316-323.
13. Shemesh E, Fine RN. Is calculating the standard deviation of tacrolimus blood levels the new gold standard for evaluating non-adherence to medications in transplant recipients? Pediatr Transplant 2010;14:940-943.
14. Annunziato RA, Baisley MC, Arrato N, Barton C, Henderling F, Arnon R, Kerkar N. Strangers headed to a strange land? A pilot study of using a transition coordinator to improve transfer from pediatric to adult services. J Pediatr 2013;163:1628-1633.
15. McDiarmid SV, Anand R, Lindblad AS; for SPLIT Research Group. Studies of Pediatric Liver Transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. Pediatr Transplant 2004;8:284-294.
16. Fink SA, Brown RS JR. Liver transplantation: indications, preoperative evaluation and posttransplantation management. In: Dancygier H, ed. Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases. 1st ed. New York, NY: Springer; 2009:1353-1381.
17. Hübscher SG. Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome. Liver Transpl 2001;7:285-291.
18. Lieber SR, Volk ML. Non-adherence and graft failure in adult liver transplant recipients. Dig Dis Sci 2013;58: 824-834.
19. Wians FH Jr. Clinical laboratory tests: which, why, and what do the results mean? Lab Medicine 2009;40:105-113.
20. Karabudak AA, Hafner J, Shetty V, Chen S, Secord AA, Morse MA, Philip R. Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels. J Cancer Res Clin Oncol 2013;139:1757-1770.
21. Kerkar N, Annunziato RA, Foley L, Schmeidler J, Rumbo C, Emre S, et al. Prospective analysis of nonadherence in autoimmune hepatitis: a common problem. J Pediatr Gastroenterol Nutr 2006;43:629-634.
22. Bucuvalas JC, Ryckman FC, Arya G, Andrew B, Lesko A, Cole CR, et al. A novel approach to managing variation: outpatient therapeutic monitoring of calcineurin inhibitor blood levels in liver transplant recipients. J Pediatr 2005;146:744-750.
23. De Geest S, Abraham I, Dunbar-Jacob J. Measuring transplant patients' compliance with immunosuppressive therapy. West J Nurs Res 1996;18:595-605.
24. Christensen A, Christrup LL, Fabricius PE, Chrostowska M, Wronka M, Narkiewicz K, Hansen EH. The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial. J Hypertens 2010;28:194-200.
25. Drent G, Haagsma EB, Geest SD, van den Berg AP, Ten Vergert EM, van den Bosch HJ, et al. Prevalence of prednisolone (non)compliance in adult liver transplant recipients. Transpl Int 2005;18:960-966.
26. Fennie KP, Bova CA, Williams AB. Adjusting and censoring electronic monitoring device data. Implications for study outcomes. J Acquir Immune Defic Syndr 2006; 43(suppl 1):S88-S95.
27. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994; 149(pt 2):S69-S76.
28. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218-1224.
29. Riekert KA, Rand CS. Electronic monitoring of medication adherence: when is high-tech best? J Clin Psychol Med Settings 2002;9:25-34.
30. Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag 2005;1:189-199.
31. Pai AL, Rausch J, Tackett A, Marsolo K, Drotar D, Goebel J. System for integrated adherence monitoring: real-time non-adherence risk assessment in pediatric kidney transplantation. Pediatr Transplant 2012;16:329-334.
32. Shemesh E. Measuring adherence to medications: are complex methods superior to simple ones? Pediatr Transplant 2012;16:315-317.
33. Chisholm-Burns MA, Spivey CA, Graff Zivin J, Lee JK, Sredzinski E, Tolley EA. Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. Am J Transplant 2013;13:2364-2373.
34. Shemesh E, Kleinman LC, Howell EA, Annunziato R. Racial and economic disparities in transplant outcomes: the not-so-hidden morbidities. Liver Transpl 2014;20:4-6.
35. Powell LH, Calvin JE Jr, Richardson D, Janssen I, Mendes de Leon CF, Flynn KJ, et al.; for HART Investigators. Self-management counseling in patients with heart failure: the Heart Failure Adherence and Retention Randomized Behavioral Trial. JAMA 2010;304:1331-1338.
36. Molloy GJ, O'Carroll RE, Witham MD, McMurdo ME. Interventions to enhance adherence to medications in patients with heart failure: a systematic review. Circ Heart Fail 2012;5:126-133.
37. Maluf DG, Stravitz RT, Cotterell AH, Posner MP, Nakatsuka M, Sterling RK, et al. Adult living donor versus deceased donor liver transplantation: a 6-year single center experience. Am J Transplant 2005;5:149-156.